The JAK2 V617F mutation in lung cancer: caveat emptor

• Datum: 2018
• 1. Verfasser: Langabeer, S.E.
• Format: Artikel
• Sprache: Englisch
• Veröffentlicht: PH Akademperiodyka 2018
• Schlagworte: JAK2 V617F
• Online Zugang: https://exp-oncology.com.ua/index.php/Exp/article/view/2018-4-1
• Назва журналу: Experimental Oncology

As acquisition of the JAK2 V617F is considered to be restricted to myeloid malignancies, the recurrent identification of this mutation in non-small cell lung cancer (NSCLC) merits discussion, particularly in the light of accumulating evidence which suggests that the JAK2 V617F may...